Abstract
Research on cell therapy for spinal cord injury has yet to achieve sufficient functional recovery. Previous studies in the field grafted oligodendrocyte progenitors, nonspinal neural stem cells or primary spinal neural progenitors. Here we sought to improve functional outcomes by grafting clinically compatible spinal cord neural stem cells derived from human embryonic stem cells (H9-scNSCs). H9-scNSCs significantly improved functional outcomes on a skilled hand task 9.2-fold (P = 2.5 × 10−27) in hemisected subjects compared with lesioned controls, achieving a fine object retrieval success of 53.4 ± 19.2%, and 2.9-fold (P = 6.3 × 10−8) superior to controls in hemicontused subjects. Recovery correlated with rehabilitation effort. Grafts extended up to hundreds of thousands of new axons into host circuits up to 39 mm below the injury, forming synapses with host circuitry. Lesion fill was substantially higher and differentiated cell-fate distributions were much closer to that of the normal spinal cord than in previous studies using primary spinal cord cells, likely enabling the observed superior functional outcomes.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout






Similar content being viewed by others
Data availability
The anatomical and behavioral data from this project are maintained in a secure, cloud-based repository platform designed to share research data, the Open Data Commons for Spinal Cord Injury (https://odc-sci.org/), ODC-SCI:1485 (https://doi.org/10.34945/F5V59G).
References
Singh, A. et al. Global prevalence and incidence of traumatic spinal cord injury. Clin. Epidemiol. 6, 309–331 (2014).
Lu, P. et al. Long-distance growth and connectivity of neural stem cells after severe spinal cord injury. Cell 150, 1264–1273 (2012).
Bonner, J. F. et al. Grafted neural progenitors integrate and restore synaptic connectivity across the injured spinal cord. J. Neurosci. 31, 4675–4686 (2011).
Lu, P. et al. Long-distance axonal growth from human induced pluripotent stem cells after spinal cord injury. Neuron 83, 789–796 (2015).
Kadoya, K. et al. Spinal cord reconstitution with homologous neural grafts enables robust corticospinal regeneration. Nat. Med. 22, 479–487 (2016).
Rosenzweig, E. S. et al. Restorative effects of human neural stem cell grafts on the primate spinal cord. Nat. Med. 24, 484–490 (2018).
Kumamaru, H. et al. Generation and post-injury integration of human spinal cord neural stem cells. Nat. Methods 15, 723–731 (2018).
Poplawski, G. H. D. et al. Adult rat myelin enhances axonal outgrowth from neural stem cells. Sci. Transl. Med. 10, eaal2563 (2018).
Koffler, J. et al. Biomimetic 3D-printed scaffolds for spinal cord injury repair. Nat. Med. 25, 263–269 (2019).
Ceto, S. et al. Neural stem cell grafts form extensive synaptic networks that integrate with host circuits after spinal cord injury. Cell Stem Cell 27, 430–440 (2020).
Poplawski, G. H. D. et al. Injured adult neurons regress to an embryonic transcriptional growth state. Nature 581, 77–82 (2020).
Salegio, E. A. et al. A unilateral cervical spinal cord contusion injury model in non-human primates (Macaca mulatta). J. Neurotrauma 33, 439–459 (2016).
Obaid, N. et al. The biomechanical implications of neck position in cervical contusion animal models of SCI. Front Neurol. 14, 1152472 (2023).
Rosenzweig, E. S. et al. Extensive spontaneous plasticity of corticospinal projections after primate spinal cord injury. Nat. Neurosci. 13, 1505–1512 (2010).
Fehlings, M. G. & Chhabra, H. S. Recent trends in spinal trauma management and research. J. Clin. Orthop. Trauma. 49, 102351 (2024).
Zheng, B. & Tuszynski, M. H. Regulation of axonal regeneration after mammalian spinal cord injury. Nat. Rev. Mol. Cell Biol. 24, 396–413 (2023).
Robinson, J. & Lu, P. Optimization of trophic support for neural stem cell grafts in sites of spinal cord injury. Exp. Neurol. 291, 87–97 (2017).
Schnell, L. & Schwab, M. E. Axonal regeneration in the rat spinal cord produced by an antibody against myelin-associated neurite growth. Nature 343, 269–272 (1990).
Ruiz-Sauri, A. et al. Glia to neuron ratio in the posterior aspect of the human spinal cord at thoracic segments relevant to spinal cord stimulation. J. Anat. 235, 997–1006 (2019).
Lu, P. et al. Motor axonal regeneration after partial and complete spinal cord transection. J. Neurosci. 32, 8208–8218 (2012).
Álvarez, Z. et al. Bioactive scaffolds with enhanced supramolecular motion promote recovery from spinal cord injury. Science 374, 848–856 (2021).
Anderson, M. A. et al. Required growth facilitators propel axon regeneration across complete spinal cord injury. Nature 561, 396–400 (2018).
Kim, K.-T. et al. Differences in morphometric measures of the uninjured porcine spinal cord and dural sac predict histological and behavioral outcomes after traumatic spinal cord injury. J. Neurotrauma 36, 3005–3017 (2019).
Fawcett, J. W. et al. Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP panel: spontaneous recovery after spinal cord injury and statistical power needed for therapeutic clinical trials. Spinal Cord. 45, 190–205 (2007).
García-Alías, G. et al. Chondroitinase ABC treatment opens a window of opportunity for task-specific rehabilitation. Nat. Neurosci. 12, 1145–1151 (2009).
Lu, P. et al. Prolonged human neural stem cell maturation supports recovery in injured rodent CNS. J. Clin. Invest. 127, 3287–3299 (2017).
Lukovic, D., Stojkovic, M., Moreno-Manzano, V., Bhattacharya, S. S. & Erceg, S. Perspectives and future directions of human pluripotent stem cell-based therapies: lessons from Geron’s clinical trial for spinal cord injury. Stem Cells Dev. 23, 1–4 (2014).
Emery, E. et al. Apoptosis after traumatic human spinal cord injury. J. Neurosurg. 89, 911–920 (1998).
Sugai, K. et al. First-in-human clinical trial of transplantation of iPSC-derived NS/PCs in subacute complete spinal cord injury: Study protocol. Regen. Ther. 18, 321–333 (2021).
Martin, J. R. et al. Long-term clinical and safety outcomes from a single-site phase 1 study of neural stem cell transplantation for chronic thoracic spinal cord injury. Cell Rep. Med. 5, 101841 (2024).
Zhang, D. et al. Spatial transcriptomics and single-nucleus RNA sequencing reveal a transcriptomic atlas of adult human spinal cord. eLife 12, RP92046 (2024).
Lu, P., Jones, L. L., Snyder, E. Y. & Tuszynski, M. H. Neural stem cells constitutively secrete neurotrophic factors and promote extensive host axonal growth after spinal cord injury. Exp. Neurol. 181, 115–129 (2003).
Fessler, R. G. et al. A phase 1/2a dose-escalation study of oligodendrocyte progenitor cells in individuals with subacute cervical spinal cord injury. J. Neurosurg. Spine 37, 812–820 (2022).
McKenna, S. L. et al. Ten-year safety of pluripotent stem cell transplantation in acute thoracic spinal cord injury. J. Neurosurg. Spine 37, 321–330 (2022).
Levi, A. D. et al. Clinical outcomes from a multi-center study of human neural stem cell transplantation in chronic cervical spinal cord injury. J. Neurotrauma 36, 891–902 (2019).
Curtis, E. et al. A first-in-human, phase I study of neural stem cell transplantation for chronic spinal cord injury. Cell Stem Cell 22, 941–950 (2018).
Mcmahon, S. S. et al. Effect of cyclosporin A on functional recovery in the spinal cord following contusion injury. J. Anat. 215, 267–279 (2009).
Madsen, J. R. et al. Tacrolimus (FK506) increases neuronal expression of GAP-43 and improves functional recovery after spinal cord injury in rats. Exp. Neurol. 154, 673–683 (1998).
Tsuruta, S. et al. The effects of cyclosporin A and insulin on ischemic spinal cord injury in rabbits. Anesth. Analg. 102, 1722–1727 (2006).
Weaver, L. C. et al. Methylprednisolone causes minimal improvement after spinal cord injury in rats, contrasting with benefits of an anti-integrin treatment. J. Neurotrauma 22, 1375–1387 (2005).
Sharp, K. G., Yee, K. M. & Steward, O. A re-assessment of treatment with a tyrosine kinase inhibitor (imatinib) on tissue sparing and functional recovery after spinal cord injury. Exp. Neurol. 254, 1–11 (2014).
Rabchevsky, A. G., Fugaccia, I., Sullivan, P. G. & Scheff, S. W. Cyclosporin A treatment following spinal cord injury to the rat: behavioral effects and stereological assessment of tissue sparing. J. Neurotrauma 18, 513–522 (2001).
Lee, J. H. T. et al. Lack of neuroprotective effects of simvastatin and minocycline in a model of cervical spinal cord injury. Exp. Neurol. 225, 219–230 (2010).
Guo, B. et al. Evaluation of benefits and risks of immunosuppressive drugs in biomaterial-based neural progenitor cell transplantation for spinal cord injury repair. Chem. Eng. J. 487, 150404 (2024).
Baloh, R. H. et al. Transplantation of human neural progenitor cells secreting GDNF into the spinal cord of patients with ALS: a phase 1/2a trial. Nat. Med. 28, 1813–1822 (2022).
Rosenzweig, E. S. et al. Extensive spinal decussation and bilateral termination of cervical corticospinal projections in rhesus monkeys. J. Comp. Neurol. 513, 151–163 (2009).
Schmidlin, E. et al. Behavioral assessment of manual dexterity in non-human primates. J. Vis. Exp. 57, 3258 (2011).
Rosenzweig, E. S. et al. Chondroitinase improves anatomical and functional outcomes after primate spinal cord injury. Nat. Neurosci. 22, 1269–1275 (2019).
Nout, Y. S. et al. Animal models of neurologic disorders: a nonhuman primate model of spinal cord injury. Neurotherapeutics 9, 380–392 (2012).
Acknowledgements
This work was supported by the Veterans Administration (Gordon Mansfield SCI Collaborative Consortium, RR&D B7332R, to M.H.T.), NIH (R01 NS104442, to M.H.T.; R01 NS105478, to J.C.B. and M.S.B.; R01 NS042291, to E.S.R.), Natural Sciences and Engineering Research Council of Canada (RGPIN 2018-06382, to C.J.S.), Canada Foundation for Innovation, the Craig H. Neilsen Foundation (to M.H.T., J.C.B. and M.S.B.), the Bernard and Anne Spitzer Charitable Trust (to M.H.T.) and the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation (to M.H.T.). Development of the contusion model was also supported by grants from the Neilsen Foundation and the NIH (R01 NS105478, to M.S.B. and J.C.B.). The consortium data and statistical coordinating center was supported by RR&D I01RX002245 (to A.R.F.). We thank E. Mendoza for statistical programming support.
Author information
Authors and Affiliations
Contributions
E.S., E.S.R., J.H.B., H.K., E.A.S., M.J.C., J.L.W., R.W., R.M., M.W.C., J.R.H., N.K., L.A.H., Y.S.N.-L., C.J.S., A.R.F., M.S.B., J.C.B. and M.H.T. designed the experiments. E.S., E.S.R., E.A.S., Y.S.N.-L., C.J.S., M.S.B., J.C.B. and M.H.T. performed surgery. E.S., E.S.R., J.H.B., J.L.W., R.W., R.M. and M.W.C. processed tissue. E.S., E.S.R., J.H.B., E.A.S., J.L.W., M.W.C., J.R.H. and N.K. imaged tissue. E.S., E.S.R., J.H.B., H.K., E.A.S., M.J.C., J.R.H., N.K., C.J.S., A.R.F., M.S.B., J.C.B. and M.H.T. analyzed the data. E.S., E.S.R., J.H.B., J.R.H., N.K., L.A.H., Y.S.N.-L., C.J.S., A.R.F., M.S.B., J.C.B. and M.H.T. wrote the paper. E.S., E.S.R., J.H.B., J.R.H., N.K., L.A.H., Y.S.N.-L., C.J.S., A.R.F., M.S.B., J.C.B. and M.H.T. edited the paper.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Peer review
Peer review information
Nature Biotechnology thanks the anonymous reviewers for their contribution to the peer review of this work.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Extended data
Extended Data Fig. 1 Graft Vascularization.
Labeling for von Willebrand factor (vWF) shows extensive vascularization of grafts, shown at various magnifications. See Methods regarding sampling methods and reproducibility. Scale Bars: A, 1 mm; B, 200 µm; C, 50 µm.
Extended Data Fig. 2 H9-scNSC Grafts in Monkeys that Underwent Hemi-contusions.
(A) S121 labeling for human cells demonstrates grafts in lesion sites of each contused monkey. There is excellent graft fill of the lesion site in 6 monkeys (#’s 9, 11-15). One monkey, #10, has surviving graft in only the rostral portion of the lesion site: this monkey therefore had very few detectable caudal axons (Fig. 6g). Monkey #10 also exhibited good functional improvement, but had the smallest contusion lesion volume among all animals (less than half the size of the mean lesion volume) and considerable right-sided tissue sparing. Thus, recovery in this subject was likely attributable to lesion incompleteness. (B) S121 labeling in contused monkeys lacking surviving grafts. Scale Bars: 1 mm.
Extended Data Fig. 3 NeuN Expression in Graft.
(A) Low-magnification view encompassing ~9 mm2 of neural stem cell graft. S121 label for human cells, NeuN label for neurons. (B) Same field of view, NeuN. Some clustering of neurons is evident. Scale Bar: 500 µm.
Extended Data Fig. 4 Olig2 Expression in Graft.
(A) Olig2-expressing cells (oligodendrocyte progenitors and both immature and mature oligodendrocytes) were distributed throughout grafts, comprising 9 ± 2% of total grafted cells. NeuN labeling shown in blue. (B) Confocal image of four Olig2+ cells (arrows) in the graft. DAPI labeling shown in gray. See Methods regarding sampling methods and reproducibility. Scale Bars: A, 100 µm; B, 10 µm.
Supplementary information
Supplementary Video 1
Right Hand Use in Grafted Hemisected Subject. Grafted hemisection subject (Monkey #2) can use right hand digits 1-3 (D1-3) in pincer motion to remove and eat a tomato from a small cup.
Supplementary Video 2
Right Hand Use in Hemisected Control Subject. Ungrafted hemisection control subject (Monkey #5) 15 weeks post injury. During manipulation and eating of a piece of fruit in the exercise cage, right hand remains in closed fist during food manipulation: digit 1(D1) is tucked in under digits 2 (D2) and 3 (D3). Left hand is normal.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Sinopoulou, E., Rosenzweig, E.S., Brock, J.H. et al. Extensive restoration of forelimb function in primates with spinal cord injury by neural stem cell transplantation. Nat Biotechnol (2025). https://doi.org/10.1038/s41587-025-02865-9
Received:
Accepted:
Published:
Version of record:
DOI: https://doi.org/10.1038/s41587-025-02865-9
This article is cited by
-
Stem cells help restore hand function after spinal cord injury in monkeys
Nature Biotechnology (2025)


